Literature DB >> 12235322

Amelioration of spinal myoclonus with levetiracetam.

S C Keswani, E H Kossoff, G L Krauss, C Hagerty.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12235322      PMCID： PMC1738068          DOI： 10.1136/jnnp.73.4.457

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  16 in total

Review 1.  An update and review of the treatment of myoclonus.

Authors:  Kelly Mills; Zoltan Mari
Journal:  Curr Neurol Neurosci Rep       Date:  2015-01       Impact factor: 5.081

2.  Myoclonus.

Authors:  Melissa J Nirenberg; Steven J Frucht
Journal:  Curr Treat Options Neurol       Date:  2005-05       Impact factor: 3.598

Review 3.  Benefit-risk assessment of levetiracetam in the treatment of partial seizures.

Authors:  Bassel Abou-Khalil
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

4.  Myoclonic disorders: a practical approach for diagnosis and treatment.

Authors:  Maja Kojovic; Carla Cordivari; Kailash Bhatia
Journal:  Ther Adv Neurol Disord       Date:  2011-01       Impact factor: 6.570

5.  An unusual presentation of diabetic amyotrophy: myoclonus.

Authors:  Syed Amir Zaidi; Suresh Kumar Chhetri; Godwin Lekwuwa; Tahir Majeed
Journal:  BMJ Case Rep       Date:  2013-02-04

Review 6.  Physiology-Based Treatment of Myoclonus.

Authors:  Ashley B Pena; John N Caviness
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

7.  Levetiracetam reduces myoclonus in corticobasal degeneration: report of two cases.

Authors:  Tibor Kovács; Marianna Farsang; Edina Vitaszil; Péter Barsi; Tamás Györke; Imre Szirmai; Anita Kamondi
Journal:  J Neural Transm (Vienna)       Date:  2009-09-12       Impact factor: 3.575

Review 8.  Treatment of myoclonus.

Authors:  John N Caviness
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

9.  Similarities in Mechanisms and Treatments for Epileptic and Nonepileptic Myoclonus.

Authors:  Gregory L. Krauss; Gregory C. Mathews
Journal:  Epilepsy Curr       Date:  2003-01       Impact factor: 7.872

Review 10.  Myoclonus: Pathophysiology and Treatment Options.

Authors:  Ariel Levy; Robert Chen
Journal:  Curr Treat Options Neurol       Date:  2016-05       Impact factor: 3.972
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.